RIGGED: University of Pennsylvania, which runs Biden's FactCheck.org, has contract with BioNTech and gets paid for vaccine sales
By ethanh // 2022-02-10
 
The more Wuhan coronavirus (Covid-19) "vaccines" Pfizer-BioNTech and Moderna sell, the more money the University of Pennsylvania makes, new documents reveal. It turns out that Joe Biden's think tank, the Penn Biden Center for Diplomacy and Global Engagement, is hosted and funded by UPenn. And the school reportedly receives "milestone payments" for every new jab that these companies produce and send to market. BioNTech reportedly pays the UPenn Board of Trustees directly, which allows for the school to never be held liable in the event that someone sues for "bodily injury" or "death" caused by one of the company's injections. BioNTech signed a licensing agreement with UPenn in 2018, providing direct funding for the Penn Biden Center. This agreement contains provisions that specifically address mRNA technology, which had not yet arrived. A few years later it would for "covid," but those who planned the plandemic first had to establish these cozy relationships to ensure their profit streams would remain untouched. "Even though Coronavirus had not yet broken out when the deal was made, the 2018 agreement ensured massive payments for the University of Pennsylvania if its technology ended up getting used in new mRNA-based vaccines," reported Infowars. "Well, UPenn's technology did end up getting used in the mRNA-based Coronavirus vaccine produced by Pfizer and BioNTech, and the deal has led to massive revenue for the university. Joe Biden, who was working for the University of Pennsylvania when the deal was made, received more than $900,000 from the University of Pennsylvania in the two years before he ran for president in this past election."

Big Pharma and Big Academia: corrupt to the core

UPenn also houses the pro-vaccine propaganda website FactCheck.org, which, of course, is tied to Big Pharma. (Related: FactCheck.org contains no facts, just lies) All of these UPenn partnerships have been so beneficial for Big Pharma's profit streams that Biden's controllers are nominating school president Amy Gutmann to the position of Ambassador to Germany. "University of Pennsylvania president Amy Gutmann is now Biden's nominee for Ambassador to Germany," reports explain. "The Biden administration's FDA has speedily approved or authorized Pfizer-BioNTech vaccines including for children – all while the Penn Biden Center's parent university enjoys massive profits from vaccine sales and FDA approval." "And the Pfizer-connected FDA even knew about numerous adverse events for children related to the Pfizer-BioNTech vaccine, but allowed children to be injected with it anyway. Now, as the FDA considers emergency use authorization for a Pfizer-BioNTech vaccine for children as young as six months old, the direct financial relationship between these vaccines and Joe Biden's think tank must be exposed." A source that spoke to National File revealed that UPenn earns "massive payments," likely in the billions, from vaccines produced by Pfizer-BioNTech and Moderna. A Dr. Drew Weissman and a Dr. Katalin Kariko are both mentioned in the documents as having received and continuing to receive "significant financial benefits" from the current and future sale of these companies' products. It also turns out that Dr. Kariko is both an adjunct professor at UPenn's Perelman School of Medicine and a vice president at BioNTech – how convenient! As for Dr. Weissman, he worked directly with the coronavirus "vaccine" research program, helping to bring the Pfizer-BioNTech mRNA (messenger RNA) variety to market at warp speed under Donald Trump. "The BLA process appears to be very lucrative for the University of Pennsylvania," reports Infowars, BLA referring to the Biologics License Applications that UPenn gets paid for every time a new one is filed for yet another new "vaccine." More related news about Big Pharma and the Biden regime can be found at Treason.news. Sources for this article include: Infowars.com NaturalNews.com